America’s 250th birthday has Elon Musk and a record IPO. Its 15th had Alexander Hamilton — and a stock market bubble

The article uses the 1791 Bank of the United States IPO and the subsequent 1792 Panic as an analogy for 2026, warning that the excitement around SpaceX’s “nearly impossible to replicate” position could fuel overspeculation. It highlights leverage mechanics from history—script priced at $25 representing $400 of equity, with debt owed over two years—and draws a parallel to at least 11 leveraged single-stock ETFs introduced after the SpaceX IPO. The implied risk is a sentiment-driven bubble dynamic rather than a fundamental earnings shock, so near-term impact is likely more behavioral than immediate fundamentals.

Analysis

This is less a single-company event than a read on market plumbing: a marquee private-market listing can extend speculative appetite and widen the gap between stories that attract leverage and businesses that simply compound fees. In that regime, the near-term winners are trading-franchise names and managers with exposure to private-markets fundraising and performance fees; the laggards are systematic/active managers that lose flows when investors chase momentum and concentration. For AAMI and HLNE, the fundamental impact is indirect and delayed by 1-3 quarters, but the multiple impact can show up immediately if investors use the event as a green light for more risk-taking.

The second-order effect is leverage. More single-name leverage and retail turnover can boost options volume, exchange activity, and primary issuance fees, while increasing the fragility of crowded beta trades. If enthusiasm broadens, public-market proxies for “innovation” can re-rate even without earnings support; if it fades, those same names de-rate faster than fundamentals would suggest because positioning is the real asset at risk.

Contrarian view: the market may be overpricing the durability of this mood shift. A disappointing pricing, lock-up, or early trading print would matter more than the IPO itself because it would puncture the narrative that speculative capital is inexhaustible. Six to 18 months out, the key falsifier is not a headline but breadth: if rates stay sticky and leadership narrows, the bubble effect reverses into a valuation reset across high-duration and levered growth exposures.

Key Decisions for Investors

• Long HLNE / short AAMI for the next 1-3 months as a sentiment-and-flows pair: HLNE should benefit more from private-market enthusiasm and fundraising psychology, while AAMI is more exposed to active-flow erosion in momentum-chasing regimes. Target 5-8% relative outperformance; cut if AAMI outperforms by >6% on a volatility spike.
• Buy a 3-6 month ARKK put spread only on a cheap-vol window or after a poor IPO trading signal. This is the cleanest hedge against a leverage unwind; upside is convex if speculative breadth breaks, but do not pay up for protection unless implied vol compresses.
• Set an alert on AAMI and HLNE relative strength versus IWM and ARKK. If both lag risk-on proxies while turnover rises, it suggests the market is preferring beta over managers; that would be a warning to reduce exposure rather than add.
• No action on MSGS unless consumer/discretionary breadth weakens materially. It is not a direct beneficiary of speculative issuance, and any trade here would be a macro-risk proxy rather than an article-specific edge.